Young-Whan Park

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

2

Total Citations

21

H-Index

2

About

Young-Whan Park is a researcher specializing in the development of innovative bioanalytical assays, with a particular focus on homogeneous, high-throughput detection methods for small molecules and proteins. Park’s major contributions lie in simplifying complex immunoassays, eliminating the need for time-consuming washing steps while maintaining high sensitivity and capacity. Notably, Park developed a high-capacity homogeneous fluorescent assay for leukotriene B4 (2005, 13 citations), a key inflammatory mediator, enabling more efficient screening in drug discovery. In a landmark study (2003, 8 citations), Park introduced a “Mix and Read” assay for insulin using fluorometric microvolume assay technology (FMAT), a novel two-step method that dramatically reduces cost and labor compared to traditional multi-wash commercial kits. This work demonstrated a linear response and full amenability to robotic automation, paving the way for streamlined, high-throughput analysis of biological samples. Park’s research is characterized by a focus on practical, time-saving solutions that bridge the gap between laboratory innovation and clinical or industrial application, making a lasting impact on assay development for both research and diagnostic settings.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4
13 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago